雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Disorders of Phosphate Metabolism. Treatment for CKD-MBD(Chronic Kidney Disease-Mineral and Bone Disorder). Iwashita Yuko 1 , Iwashita Yu 2 , Ito Takafumi 3 , Shigematsu Takashi 4 1Department of Nephrology, Wakayama Medical University, Japan. 2Department of Nephrology, Wakayama Medical University, Japan. 3Department of Nephrology, Faculty of Medicine, Shimane University, Japan. 4Department of Nephrology, Wakayama Medical University, Japan. pp.259-267
Published Date 2016/1/28
DOI https://doi.org/10.20837/4201602259
  • Abstract
  • Look Inside
  • Reference

 CKD is a common disease that is estimated to develop one in eight persons in Japan.The CKD itself is highly risk factor on the cardiac/vascular mortality. In addition,a new concept has been proposed “CKD-MBD”.CKD-MBD is composed of a combination of abnormal mineral metabolism, abnormal bone, and extra skeletal calcification with cardiovascular high mortality. Treatment for CKD-MBD is a wide-ranging.We aim to decline cardiovascular event, fracture, and mortality rate of patients with CKD. The main therapeutic target for CKD-MBD becomes the phosphate control. Today, we can use of the VRDA, Calcimimetics and muti-phosphate binders as a lot of pharmacological intervention.



基本情報

電子版ISSN 印刷版ISSN 0917-5857 医薬ジャーナル社

関連文献

もっと見る

文献を共有